Every 8-K that QT IMAGING HOLDINGS WTS (QTIWW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow QTIWW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QTIWW filings page.
QT Imaging Holdings, Inc. outlined strong mid‑year 2026 progress built around its radiation‑free Breast Acoustic CT imaging platform. In the first half of 2026, the company generated $14.0 million in revenue, up 116% year over year, and shipped 28 scanners. Annual revenue was $4.9 million in 2024 and $18.9 million in 2025, with 2026 revenue guidance of approximately $39 million. More than 12,000 women have been imaged on the platform to date.
QT Imaging completed a $10 million underwritten public offering, extended its senior secured term loan maturity to March 31, 2029, and reported $14.2 million in cash and restricted cash as of August 7, 2026. The company regained listing on the Nasdaq Capital Market and was added to the Russell Microcap Index. Two new FDA clearances expanded system capabilities, and a first routine FDA inspection concluded with zero Form 483 observations. Internationally, QT Imaging obtained regulatory authorizations in Saudi Arabia, the United Arab Emirates, and Israel, and secured a dedicated Category III CPT code for 3D quantitative transmission volumetric breast ultrasound, effective January 1, 2027. The company is relocating to a 22,000‑square‑foot Petaluma facility, more than 2.5x current space with roughly 55% lower lease cost per square foot, to support manufacturing scale and long‑term growth.
QT Imaging Holdings, Inc. reported rapid top-line growth while remaining loss-making for the quarter ended June 30, 2026. Revenue for the second quarter was $7.4 million, up 103% from $3.7 million a year earlier, driven by shipments of fifteen Breast Acoustic CT scanners versus eight in the prior-year quarter. First-half revenue was $14.0 million, up 116% from $6.5 million.
Gross margin was 41%, down from 50% a year ago, reflecting mix and inventory cost dynamics. Total operating expenses rose to $4.9 million from $2.9 million, mainly from higher compensation, professional services, and marketing, resulting in an operating loss of $1.9 million versus a $1.0 million loss last year. A largely non-cash $8.3 million loss on debt extinguishment and modification related to the Lynrock Lake term loan drove total interest and other expense to $9.2 million and pushed net loss to $11.1 million, or $0.75 per share.
Non-GAAP adjusted EBITDA was –$1.2 million. Net cash used in operating activities for the quarter was $4.8 million. QT Imaging strengthened liquidity via an underwritten public offering generating approximately $10.0 million in gross proceeds and extended the maturity of its senior secured term loan from March 2027 to March 2029. Cash and restricted cash totaled $11.0 million as of June 30, 2026 and $14.2 million as of August 7, 2026. The company reaffirmed its 2026 revenue guidance of approximately $39 million and highlighted regulatory wins, expanded manufacturing capacity, and a clean first routine FDA inspection with zero Form 483 observations.
QT Imaging Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on July 28, 2026. Of the 13,768,903 shares of common stock outstanding and entitled to vote, 8,698,769 shares were represented, constituting a quorum.
Stockholders elected Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the 2029 Annual Meeting. They also ratified BPM LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 and approved an amendment to the 2024 Equity Incentive Plan to increase shares authorized and reserved for issuance.
QT Imaging Holdings reported strong first quarter 2026 growth, with revenue of $6.5 million, up 133% from $2.8 million a year earlier, driven by shipments of 13 Breast Acoustic CT scanners versus six in the prior-year period.
Gross margin was 41% compared with 65%, reflecting mix effects, while operating expenses rose to $5.0 million from $2.9 million, leading to a net loss of $3.4 million, a notable improvement from $11.1 million. Cash, restricted cash, and cash equivalents were $7.0 million as of March 31, 2026.
The company extended the maturity of its senior secured term loan to March 31, 2029 and increased the interest rate to 12.0% per annum. It also secured a dedicated Category III CPT code effective January 1, 2027, obtained FDA 510(k) clearance for scanner enhancements, and reaffirmed 2026 revenue guidance of approximately $39 million supported by minimum order commitments and a multiyear UAE distribution agreement totaling more than $24 million in scanner revenue.
QT Imaging Holdings, Inc. updated compensation for its top executives. The Board increased Chief Executive Officer Dr. Raluca Dinu’s annual base salary from $550,000 to $605,000, effective March 20, 2026, and approved a cash bonus of $231,993 for her.
Chief Financial Officer Jay Jennings received a cash bonus of $40,576. The Board also granted Dr. Dinu a total of 519,500 restricted stock units (RSUs), split into grants of 3,500, 16,000 and 500,000 RSUs, vesting in scheduled installments from May 15, 2026 through February 15, 2030, contingent on continued service.
Mr. Jennings received a grant of 2,800 RSUs, with 933 RSUs vesting on May 15, 2027 and the remaining 1,867 RSUs vesting in eight quarterly installments through May 15, 2029, also subject to his continued service with the company.
QT Imaging Holdings, Inc. released an investor presentation highlighting rapid commercial growth for its breast imaging platform and updated financials. Revenue reached $18.9 million in 2025, up from $4.9 million in 2024, driven by shipment of 40 QT Breast Acoustic CT scanners under distribution agreements.
Q4 2025 revenue was $8.3 million, an 877% year-over-year increase, with 38% gross margin and a net loss of $1.4 million. Adjusted EBITDA improved to $(0.4) million from $(1.9) million a year earlier. The company ended 2025 with $10.5 million in cash after an oversubscribed $18.2 million private placement and new debt financing, and it expects approximately $39 million of revenue in 2026, including initial SaaS cloud platform contributions.
QT Imaging Holdings, Inc. reported preliminary unaudited results showing record revenue of $8.3 million in Q4 2025 and $18.9 million for full-year 2025, exceeding its $18 million outlook. Q4 revenue rose 877% year over year and 97% sequentially, driven by shipment of 17 Breast Acoustic CT™ scanners.
For 2025, revenue grew 288% versus 2024, with 40 scanners shipped. Gross margin was 45% for the year and 38% in Q4. Despite this growth, the company recorded a 2025 net loss of $21.1 million, influenced by $8.8 million of other expense tied to term loan issuance, note extinguishments and fair value changes.
Non-GAAP Adjusted EBITDA improved to $(3.5) million from $(7.4) million in 2024, while net cash used in operating activities narrowed to $9.0 million. Cash, restricted cash and equivalents reached $10.5 million at year-end 2025 after an $18.2 million private placement and new debt financings. The company relisted on Nasdaq and is pivoting from pure hardware to a SaaS and biomarker-driven imaging platform, and it projects 2026 revenue of about $39 million, including initial SaaS Cloud Platform contributions.
QT Imaging Holdings, Inc. reports that Nasdaq has approved the listing of its common stock on the Nasdaq Capital Market. The shares are expected to begin trading under the ticker symbol “QTI” on January 28, 2026, moving from a prior trading venue not described here.
The company highlights that this uplisting remains subject to meeting Nasdaq’s ongoing listing standards and pairs the news with an extensive caution about forward-looking statements. It notes risks around successfully commercializing its QT Imaging Breast Acoustic CT™ Scanner, expanding product offerings, securing financing, addressing a material weakness in internal controls, and meeting business milestones. A press release announcing the uplisting is filed as Exhibit 99.1.
QT Imaging Holdings, Inc. entered into a private placement on January 22, 2026 with its board chairman, Dr. Avi Katz. The company sold 24,107 shares of common stock at $6.43 per share, a price equal to 110% of the 5-day volume-weighted average, and issued a 10-year warrant to purchase up to 48,214 additional shares at the same exercise price. Gross proceeds were about $155,002, which the company plans to use for working capital.
The parties signed a Securities Purchase Agreement and a Registration Rights Agreement. QT Imaging agreed to register the resale of the purchased shares and warrant shares within specified deadlines, with cash liquidated damages of 0.5% of the subscription amount per month if certain resale-blocking events occur. The company also filed unaudited pro forma financial information reflecting this transaction, an earlier October 2025 private placement of approximately $18,180,655, and repayment of $5,360,477 of debt to Lynrock Lake Master Fund LP as if these occurred on January 1, 2025.
QT Imaging Holdings, Inc. entered into an exclusive distribution agreement with Al Naghi Medical Co. for the United Arab Emirates. Al Naghi receives exclusive rights to market, advertise and sell QT Breast Acoustic CT Scanners and QTI Cloud Platform SaaS subscriptions in the territory, while QT Imaging retains all intellectual property rights and provides training and professional services.
The agreement runs from January 19, 2026 through January 19, 2029, with an automatic one-year extension if specified minimum purchase and revenue targets are met. If Al Naghi does not meet these minimum requirements in any year, QT Imaging may either end exclusivity in the UAE or terminate the agreement. Al Naghi handles regulatory clearances, logistics, shipping costs and local taxes, and typically pays 50% of each order at placement and 50% within 45 days of shipment. QT Imaging offers limited product warranties ranging from at least one year up to five years, depending on client purchase price.
QT Imaging Holdings, Inc. reported that it has prepared and furnished unaudited pro forma condensed consolidated statements of operations and comprehensive loss for each quarter from December 31, 2024 through September 30, 2025. These pro forma statements show how results would look if certain 2025 financing and debt transactions had been in place starting January 1, 2024.
The pro forma information reflects a September 30, 2025 private placement of securities that closed on October 3, 2025, providing aggregate gross proceeds of about $18,180,655 before offering expenses. It also incorporates the October 6, 2025 repayment to Lynrock Lake Master Fund LP of $5.0 million of long-term debt, plus $360,477 of accrued interest and a Tranche B 2025 premium under an amended credit agreement.
In addition, the pro forma figures remove expenses and losses tied to extinguishment or modification of prior debt repaid in February 2025 and the issuance of the Lynrock Lake term loan, as well as certain non-cash items such as interest expense and changes in the fair value of warrant, derivative, and earnout liabilities.
QT Imaging Holdings, Inc. filed an update providing unaudited pro forma financial information for the nine months ended September 30, 2025. The pro forma statements show how its balance sheet and results would look if a previously completed private placement and a subsequent debt repayment had occurred on January 1, 2025.
The company completed a private placement of securities on September 30, 2025, which closed on October 3, 2025, generating aggregate gross proceeds of about $18,180,655 before offering expenses. The pro forma information also reflects the October 6, 2025 repayment of $5.0 million of long-term debt, plus $360,477 of accrued interest and the Tranche B 2025 Premium, totaling $5,360,477 paid to Lynrock Lake Master Fund LP. These adjustments help illustrate the company’s capital structure and loss profile as if these financing actions had been in place for the full period.
QT Imaging Holdings, Inc. furnished an investor presentation under Item 7.01 (Reg FD). On November 10, 2025, the company posted the presentation to its website and furnished it as Exhibit 99.1 to an 8‑K. The information is being furnished, not filed, is not subject to Section 18 liabilities, and is not incorporated by reference into other filings. The company directs readers to Exhibit 99.1 for forward‑looking statements and related risks.
QT Imaging Holdings, Inc. submitted a current report describing that it has released its financial results for the three months ended September 30, 2025. The company announced these quarterly results in a separate press release dated November 10, 2025, which is attached as Exhibit 99.1.
The report specifies that the earnings information in Item 2.02 and Exhibit 99.1 is being furnished to the SEC rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other registration statements. The filing also notes that the press release includes forward-looking statements and related risk disclosures.
QT Imaging Holdings, Inc. (QTIH) announced market effectiveness of a 3:1 reverse stock split on October 24, 2025. The company disclosed the update via a press release titled “QT Imaging 3:1 Reverse Stock Split Market Effective on October 24, 2025,” furnished as Exhibit 99.1.
The notice was provided under Item 8.01 (Other Events) in a current report, with the filing signed by Chief Executive Officer Raluca Dinu.
QT Imaging Holdings, Inc. implemented a reverse stock split of its common stock at a 3:1 ratio. The Certificate of Amendment became effective at 4:01 p.m. Eastern Time on October 23, 2025.
The company’s common stock will begin trading on the OTCQB Venture Market on a reverse split‑adjusted basis on October 24, 2025. Stockholders previously approved a reverse split within a 2:1 to 20:1 range, and the board set the final ratio at 3:1.
QT Imaging Holdings, Inc. filed an amended current report to add the full agreements related to its Chief Financial Officer’s resignation. On August 22, 2025, Anastas Budagov informed the board he would resign as CFO effective August 29, 2025. He was not contractually entitled to severance, but the parties entered into a Separation and Release Agreement under which he will receive $150,000 in lieu of severance in exchange for a release of all claims against the company.
The company and Mr. Budagov also signed a Consulting Agreement. From August 29, 2025 through November 15, 2025, he will serve as an advisor at an hourly rate of $180, payable monthly, with an aggregate cap of $20,000 that the company can change with prior written notice. He is generally not expected to work more than ten hours per week unless adjusted. His outstanding stock options will continue to vest under their existing terms during the consulting period.